Can we replace first line targeted therapy with immune therapy in renal cancer?

Date 09 December 2017
Event ESMO Immuno-Oncology Congress 2017
Session What’s new in genitourinary (GU) tumours
Topics Anticancer Agents
Bioethics, Legal, and Economic Issues
Prostate Cancer
Genitourinary Cancers
Therapy
Biological Therapy
Presenter Laurence Albiges
Authors L. Albiges
  • Medical Oncology, Institut Gustave Roussy, 94805 - Villejuif/FR